Europe Parkinsons Disease Drug Market Report 2016

October 2016 | 121 pages | ID: E05640A5842EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Parkinsons Disease Drug

Revenue, means the sales value of Parkinsons Disease Drug

This report studies sales (consumption) of Parkinsons Disease Drug in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

• GSK
• Novartis
• Boehringer Ingelheim
• Teva Pharmaceutical
• Abbvie
• Merck
• Akorn
• Astellas Pharma
• Desitin Arzneimittel
• Endo Pharmaceuticals
• F.Hoffmann-La Roche
• H.Lundbeck
• Kyowa Hakko Kirin Pharma
• Orion
• Stada Arzneimittel
• Valeant
• Apokyn

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Parkinsons Disease Drug in these countries, from 2011 to 2021 (forecast), like

• Germany
• France
• UK
• Russia
• Italy
• Spain
• Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by application, this report focuses on sales, market share and growth rate of Parkinsons Disease Drug in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Europe Parkinsons Disease Drug Market Report 2016

1 PARKINSONS DISEASE DRUG OVERVIEW

1.1 Product Overview and Scope of Parkinsons Disease Drug
1.2 Classification of Parkinsons Disease Drug
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Parkinsons Disease Drug
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Parkinsons Disease Drug Market by Countries
  1.4.1 Germany Status and Prospect (2011-2021)
  1.4.2 France Status and Prospect (2011-2021)
  1.4.3 UK Status and Prospect (2011-2021)
  1.4.4 Russia Status and Prospect (2011-2021)
  1.4.5 Italy Status and Prospect (2011-2021)
  1.4.6 Spain Status and Prospect (2011-2021)
  1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Parkinsons Disease Drug (2011-2021)
  1.5.1 Europe Parkinsons Disease Drug Sales and Growth Rate (2011-2021)
  1.5.2 Europe Parkinsons Disease Drug Revenue and Growth Rate (2011-2021)

2 EUROPE PARKINSONS DISEASE DRUG BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe Parkinsons Disease Drug Market Competition by Manufacturers
  2.1.1 Europe Parkinsons Disease Drug Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe Parkinsons Disease Drug Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Parkinsons Disease Drug (Volume and Value) by Type
  2.2.1 Europe Parkinsons Disease Drug Sales and Market Share by Type (2011-2016)
  2.2.2 Europe Parkinsons Disease Drug Revenue and Market Share by Type (2011-2016)
2.3 Europe Parkinsons Disease Drug (Volume and Value) by Countries
  2.3.1 Europe Parkinsons Disease Drug Sales and Market Share by Countries (2011-2016)
  2.3.2 Europe Parkinsons Disease Drug Revenue and Market Share by Countries (2011-2016)
2.4 Europe Parkinsons Disease Drug (Volume) by Application

3 GERMANY PARKINSONS DISEASE DRUG (VOLUME, VALUE AND SALES PRICE)

3.1 Germany Parkinsons Disease Drug Sales and Value (2011-2016)
  3.1.1 Germany Parkinsons Disease Drug Sales and Growth Rate (2011-2016)
  3.1.2 Germany Parkinsons Disease Drug Revenue and Growth Rate (2011-2016)
  3.1.3 Germany Parkinsons Disease Drug Sales Price Trend (2011-2016)
3.2 Germany Parkinsons Disease Drug Sales and Market Share by Manufacturers
3.3 Germany Parkinsons Disease Drug Sales and Market Share by Type
3.4 Germany Parkinsons Disease Drug Sales and Market Share by Application

4 FRANCE PARKINSONS DISEASE DRUG (VOLUME, VALUE AND SALES PRICE)

4.1 France Parkinsons Disease Drug Sales and Value (2011-2016)
  4.1.1 France Parkinsons Disease Drug Sales and Growth Rate (2011-2016)
  4.1.2 France Parkinsons Disease Drug Revenue and Growth Rate (2011-2016)
  4.1.4 France Parkinsons Disease Drug Sales Price Trend (2011-2016)
4.2 France Parkinsons Disease Drug Sales and Market Share by Manufacturers
4.3 France Parkinsons Disease Drug Sales and Market Share by Type
4.4 France Parkinsons Disease Drug Sales and Market Share by Application

5 UK PARKINSONS DISEASE DRUG (VOLUME, VALUE AND SALES PRICE)

5.1 UK Parkinsons Disease Drug Sales and Value (2011-2016)
  5.1.1 UK Parkinsons Disease Drug Sales and Growth Rate (2011-2016)
  5.1.2 UK Parkinsons Disease Drug Revenue and Growth Rate (2011-2016)
  5.1.5 UK Parkinsons Disease Drug Sales Price Trend (2011-2016)
5.2 UK Parkinsons Disease Drug Sales and Market Share by Manufacturers
5.3 UK Parkinsons Disease Drug Sales and Market Share by Type
5.4 UK Parkinsons Disease Drug Sales and Market Share by Application

6 RUSSIA PARKINSONS DISEASE DRUG (VOLUME, VALUE AND SALES PRICE)

6.1 Russia Parkinsons Disease Drug Sales and Value (2011-2016)
  6.1.1 Russia Parkinsons Disease Drug Sales and Growth Rate (2011-2016)
  6.1.2 Russia Parkinsons Disease Drug Revenue and Growth Rate (2011-2016)
  6.1.6 Russia Parkinsons Disease Drug Sales Price Trend (2011-2016)
6.2 Russia Parkinsons Disease Drug Sales and Market Share by Manufacturers
6.3 Russia Parkinsons Disease Drug Sales and Market Share by Type
6.4 Russia Parkinsons Disease Drug Sales and Market Share by Application

7 ITALY PARKINSONS DISEASE DRUG (VOLUME, VALUE AND SALES PRICE)

7.1 Italy Parkinsons Disease Drug Sales and Value (2011-2016)
  7.1.1 Italy Parkinsons Disease Drug Sales and Growth Rate (2011-2016)
  7.1.2 Italy Parkinsons Disease Drug Revenue and Growth Rate (2011-2016)
  7.1.7 Italy Parkinsons Disease Drug Sales Price Trend (2011-2016)
7.2 Italy Parkinsons Disease Drug Sales and Market Share by Manufacturers
7.3 Italy Parkinsons Disease Drug Sales and Market Share by Type
7.4 Italy Parkinsons Disease Drug Sales and Market Share by Application

8 SPAIN PARKINSONS DISEASE DRUG (VOLUME, VALUE AND SALES PRICE)

8.1 Spain Parkinsons Disease Drug Sales and Value (2011-2016)
  8.1.1 Spain Parkinsons Disease Drug Sales and Growth Rate (2011-2016)
  8.1.2 Spain Parkinsons Disease Drug Revenue and Growth Rate (2011-2016)
  8.1.8 Spain Parkinsons Disease Drug Sales Price Trend (2011-2016)
8.2 Spain Parkinsons Disease Drug Sales and Market Share by Manufacturers
8.3 Spain Parkinsons Disease Drug Sales and Market Share by Type
8.4 Spain Parkinsons Disease Drug Sales and Market Share by Application

9 BENELUX PARKINSONS DISEASE DRUG (VOLUME, VALUE AND SALES PRICE)

9.1 Benelux Parkinsons Disease Drug Sales and Value (2011-2016)
  9.1.1 Benelux Parkinsons Disease Drug Sales and Growth Rate (2011-2016)
  9.1.2 Benelux Parkinsons Disease Drug Revenue and Growth Rate (2011-2016)
  9.1.9 Benelux Parkinsons Disease Drug Sales Price Trend (2011-2016)
9.2 Benelux Parkinsons Disease Drug Sales and Market Share by Manufacturers
9.3 Benelux Parkinsons Disease Drug Sales and Market Share by Type
9.4 Benelux Parkinsons Disease Drug Sales and Market Share by Application

10 EUROPE PARKINSONS DISEASE DRUG MANUFACTURERS ANALYSIS

10.1 GSK
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Parkinsons Disease Drug Product Type, Application and Specification
    10.1.2.1 Type I
    10.1.2.2 Type II
  10.1.3 GSK Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  10.1.4 Main Business/Business Overview
10.2 Novartis
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Parkinsons Disease Drug Product Type, Application and Specification
    10.2.2.1 Type I
    10.2.2.2 Type II
  10.2.3 Novartis Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  10.2.4 Main Business/Business Overview
10.3 Boehringer Ingelheim
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Parkinsons Disease Drug Product Type, Application and Specification
    10.3.2.1 Type I
    10.3.2.2 Type II
  10.3.3 Boehringer Ingelheim Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  10.3.4 Main Business/Business Overview
10.4 Teva Pharmaceutical
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Parkinsons Disease Drug Product Type, Application and Specification
    10.4.2.1 Type I
    10.4.2.2 Type II
  10.4.3 Teva Pharmaceutical Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  10.4.4 Main Business/Business Overview
10.5 Abbvie
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Parkinsons Disease Drug Product Type, Application and Specification
    10.5.2.1 Type I
    10.5.2.2 Type II
  10.5.3 Abbvie Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  10.5.4 Main Business/Business Overview
10.6 Merck
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Parkinsons Disease Drug Product Type, Application and Specification
    10.6.2.1 Type I
    10.6.2.2 Type II
  10.6.3 Merck Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  10.6.4 Main Business/Business Overview
10.7 Akorn
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Parkinsons Disease Drug Product Type, Application and Specification
    10.7.2.1 Type I
    10.7.2.2 Type II
  10.7.3 Akorn Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  10.7.4 Main Business/Business Overview
10.8 Astellas Pharma
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Parkinsons Disease Drug Product Type, Application and Specification
    10.8.2.1 Type I
    10.8.2.2 Type II
  10.8.3 Astellas Pharma Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  10.8.4 Main Business/Business Overview
10.9 Desitin Arzneimittel
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Parkinsons Disease Drug Product Type, Application and Specification
    10.9.2.1 Type I
    10.9.2.2 Type II
  10.9.3 Desitin Arzneimittel Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  10.9.4 Main Business/Business Overview
10.10 Endo Pharmaceuticals
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Parkinsons Disease Drug Product Type, Application and Specification
    10.10.2.1 Type I
    10.10.2.2 Type II
  10.10.3 Endo Pharmaceuticals Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  10.10.4 Main Business/Business Overview
10.11 F.Hoffmann-La Roche
10.12 H.Lundbeck
10.13 Kyowa Hakko Kirin Pharma
10.14 Orion
10.15 Stada Arzneimittel
10.16 Valeant
10.17 Apokyn

11 PARKINSONS DISEASE DRUG MANUFACTURING COST ANALYSIS

11.1 Parkinsons Disease Drug Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Parkinsons Disease Drug

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Parkinsons Disease Drug Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Parkinsons Disease Drug Major Manufacturers in 2015
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 EUROPE PARKINSONS DISEASE DRUG MARKET FORECAST (2016-2021)

14.1 Germany Parkinsons Disease Drug Sales Forecast (2016-2021)
14.2 France Parkinsons Disease Drug Sales Forecast (2016-2021)
14.3 UK Parkinsons Disease Drug Sales Forecast (2016-2021)
14.4 Russia Parkinsons Disease Drug Sales Forecast (2016-2021)
14.5 Italy Parkinsons Disease Drug Sales Forecast (2016-2021)
14.6 Spain Parkinsons Disease Drug Sales Forecast (2016-2021)
14.7 Benelux Parkinsons Disease Drug Sales Forecast (2016-2021)
14.8 Europe Parkinsons Disease Drug Sales Forecast by Type (2016-2021)
14.9 Europe Parkinsons Disease Drug Sales Forecast by Application (2016-2021)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Parkinsons Disease Drug
Table Classification of Parkinsons Disease Drug
Figure Europe Sales Market Share of Parkinsons Disease Drug by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Application of Parkinsons Disease Drug
Figure Europe Sales Market Share of Parkinsons Disease Drug by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Germany Parkinsons Disease Drug Revenue and Growth Rate (2011-2021)
Figure France Parkinsons Disease Drug Revenue and Growth Rate (2011-2021)
Figure UK Parkinsons Disease Drug Revenue and Growth Rate (2011-2021)
Figure Russia Parkinsons Disease Drug Revenue and Growth Rate (2011-2021)
Figure Italy Parkinsons Disease Drug Revenue and Growth Rate (2011-2021)
Figure Spain Parkinsons Disease Drug Revenue and Growth Rate (2011-2021)
Figure Benelux Parkinsons Disease Drug Revenue and Growth Rate (2011-2021)
Figure Europe Parkinsons Disease Drug Sales and Growth Rate (2011-2021)
Figure Europe Parkinsons Disease Drug Revenue and Growth Rate (2011-2021)
Table Europe Parkinsons Disease Drug Sales of Key Manufacturers (2015 and 2016)
Table Europe Parkinsons Disease Drug Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Parkinsons Disease Drug Sales Share by Manufacturers
Figure 2016 Parkinsons Disease Drug Sales Share by Manufacturers
Table Europe Parkinsons Disease Drug Revenue by Manufacturers (2015 and 2016)
Table Europe Parkinsons Disease Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Parkinsons Disease Drug Revenue Share by Manufacturers
Table 2016 Europe Parkinsons Disease Drug Revenue Share by Manufacturers
Table Europe Parkinsons Disease Drug Sales and Market Share by Type (2011-2016)
Table Europe Parkinsons Disease Drug Sales Share by Type (2011-2016)
Figure Sales Market Share of Parkinsons Disease Drug by Type (2011-2016)
Figure Europe Parkinsons Disease Drug Sales Growth Rate by Type (2011-2016)
Table Europe Parkinsons Disease Drug Revenue and Market Share by Type (2011-2016)
Table Europe Parkinsons Disease Drug Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Parkinsons Disease Drug by Type (2011-2016)
Figure Europe Parkinsons Disease Drug Revenue Growth Rate by Type (2011-2016)
Table Europe Parkinsons Disease Drug Sales and Market Share by Countries (2011-2016)
Table Europe Parkinsons Disease Drug Sales Share by Countries (2011-2016)
Figure Sales Market Share of Parkinsons Disease Drug by Countries (2011-2016)
Table Europe Parkinsons Disease Drug Revenue and Market Share by Countries (2011-2016)
Table Europe Parkinsons Disease Drug Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Parkinsons Disease Drug by Countries (2011-2016)
Table Europe Parkinsons Disease Drug Sales and Market Share by Application (2011-2016)
Table Europe Parkinsons Disease Drug Sales Share by Application (2011-2016)
Figure Sales Market Share of Parkinsons Disease Drug by Application (2011-2016)
Figure Germany Parkinsons Disease Drug Sales and Growth Rate (2011-2016)
Figure Germany Parkinsons Disease Drug Revenue and Growth Rate (2011-2016)
Figure Germany Parkinsons Disease Drug Sales Price Trend (2011-2016)
Table Germany Parkinsons Disease Drug Sales by Manufacturers (2015 and 2016)
Table Germany Parkinsons Disease Drug Market Share by Manufacturers (2015 and 2016)
Table Germany Parkinsons Disease Drug Sales by Type (2015 and 2016)
Table Germany Parkinsons Disease Drug Market Share by Type (2015 and 2016)
Table Germany Parkinsons Disease Drug Sales by Application (2015 and 2016)
Table Germany Parkinsons Disease Drug Market Share by Application (2015 and 2016)
Figure France Parkinsons Disease Drug Sales and Growth Rate (2011-2016)
Figure France Parkinsons Disease Drug Revenue and Growth Rate (2011-2016)
Figure France Parkinsons Disease Drug Sales Price Trend (2011-2016)
Table France Parkinsons Disease Drug Sales by Manufacturers (2015 and 2016)
Table France Parkinsons Disease Drug Market Share by Manufacturers (2015 and 2016)
Table France Parkinsons Disease Drug Sales by Type (2015 and 2016)
Table France Parkinsons Disease Drug Market Share by Type (2015 and 2016)
Table France Parkinsons Disease Drug Sales by Application (2015 and 2016)
Table France Parkinsons Disease Drug Market Share by Application (2015 and 2016)
Figure UK Parkinsons Disease Drug Sales and Growth Rate (2011-2016)
Figure UK Parkinsons Disease Drug Revenue and Growth Rate (2011-2016)
Figure UK Parkinsons Disease Drug Sales Price Trend (2011-2016)
Table UK Parkinsons Disease Drug Sales by Manufacturers (2015 and 2016)
Table UK Parkinsons Disease Drug Market Share by Manufacturers (2015 and 2016)
Table UK Parkinsons Disease Drug Sales by Type (2015 and 2016)
Table UK Parkinsons Disease Drug Market Share by Type (2015 and 2016)
Table UK Parkinsons Disease Drug Sales by Application (2015 and 2016)
Table UK Parkinsons Disease Drug Market Share by Application (2015 and 2016)
Figure Russia Parkinsons Disease Drug Sales and Growth Rate (2011-2016)
Figure Russia Parkinsons Disease Drug Revenue and Growth Rate (2011-2016)
Figure Russia Parkinsons Disease Drug Sales Price Trend (2011-2016)
Table Russia Parkinsons Disease Drug Sales by Manufacturers (2015 and 2016)
Table Russia Parkinsons Disease Drug Market Share by Manufacturers (2015 and 2016)
Table Russia Parkinsons Disease Drug Sales by Type (2015 and 2016)
Table Russia Parkinsons Disease Drug Market Share by Type (2015 and 2016)
Table Russia Parkinsons Disease Drug Sales by Application (2015 and 2016)
Table Russia Parkinsons Disease Drug Market Share by Application (2015 and 2016)
Figure Italy Parkinsons Disease Drug Sales and Growth Rate (2011-2016)
Figure Italy Parkinsons Disease Drug Revenue and Growth Rate (2011-2016)
Figure Italy Parkinsons Disease Drug Sales Price Trend (2011-2016)
Table Italy Parkinsons Disease Drug Sales by Manufacturers (2015 and 2016)
Table Italy Parkinsons Disease Drug Market Share by Manufacturers (2015 and 2016)
Table Italy Parkinsons Disease Drug Sales by Type (2015 and 2016)
Table Italy Parkinsons Disease Drug Market Share by Type (2015 and 2016)
Table Italy Parkinsons Disease Drug Sales by Application (2015 and 2016)
Table Italy Parkinsons Disease Drug Market Share by Application (2015 and 2016)
Figure Spain Parkinsons Disease Drug Sales and Growth Rate (2011-2016)
Figure Spain Parkinsons Disease Drug Revenue and Growth Rate (2011-2016)
Figure Spain Parkinsons Disease Drug Sales Price Trend (2011-2016)
Table Spain Parkinsons Disease Drug Sales by Manufacturers (2015 and 2016)
Table Spain Parkinsons Disease Drug Market Share by Manufacturers (2015 and 2016)
Table Spain Parkinsons Disease Drug Sales by Type (2015 and 2016)
Table Spain Parkinsons Disease Drug Market Share by Type (2015 and 2016)
Table Spain Parkinsons Disease Drug Sales by Application (2015 and 2016)
Table Spain Parkinsons Disease Drug Market Share by Application (2015 and 2016)
Figure Benelux Parkinsons Disease Drug Sales and Growth Rate (2011-2016)
Figure Benelux Parkinsons Disease Drug Revenue and Growth Rate (2011-2016)
Figure Benelux Parkinsons Disease Drug Sales Price Trend (2011-2016)
Table Benelux Parkinsons Disease Drug Sales by Manufacturers (2015 and 2016)
Table Benelux Parkinsons Disease Drug Market Share by Manufacturers (2015 and 2016)
Table Benelux Parkinsons Disease Drug Sales by Type (2015 and 2016)
Table Benelux Parkinsons Disease Drug Market Share by Type (2015 and 2016)
Table Benelux Parkinsons Disease Drug Sales by Application (2015 and 2016)
Table Benelux Parkinsons Disease Drug Market Share by Application (2015 and 2016)
Table Parkinsons Disease Drug Basic Information List
Table GSK Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure GSK Parkinsons Disease Drug Sales Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis Parkinsons Disease Drug Sales Market Share (2011-2016)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Ingelheim Parkinsons Disease Drug Sales Market Share (2011-2016)
Table Teva Pharmaceutical Basic Information List
Table Teva Pharmaceutical Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Teva Pharmaceutical Parkinsons Disease Drug Sales Market Share (2011-2016)
Table Abbvie Basic Information List
Table Abbvie Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abbvie Parkinsons Disease Drug Sales Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Parkinsons Disease Drug Sales Market Share (2011-2016)
Table Akorn Basic Information List
Table Akorn Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Akorn Parkinsons Disease Drug Sales Market Share (2011-2016)
Table Astellas Pharma Basic Information List
Table Astellas Pharma Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Astellas Pharma Parkinsons Disease Drug Sales Market Share (2011-2016)
Table Desitin Arzneimittel Basic Information List
Table Desitin Arzneimittel Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Desitin Arzneimittel Parkinsons Disease Drug Sales Market Share (2011-2016)
Table Endo Pharmaceuticals Basic Information List
Table Endo Pharmaceuticals Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Endo Pharmaceuticals Parkinsons Disease Drug Sales Market Share (2011-2016)
Table F.Hoffmann-La Roche Basic Information List
Table F.Hoffmann-La Roche Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table F.Hoffmann-La Roche Parkinsons Disease Drug Sales Market Share (2011-2016)
Table H.Lundbeck Basic Information List
Table H.Lundbeck Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table H.Lundbeck Parkinsons Disease Drug Sales Market Share (2011-2016)
Table Kyowa Hakko Kirin Pharma Basic Information List
Table Kyowa Hakko Kirin Pharma Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Kyowa Hakko Kirin Pharma Parkinsons Disease Drug Sales Market Share (2011-2016)
Table Orion Basic Information List
Table Orion Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Orion Parkinsons Disease Drug Sales Market Share (2011-2016)
Table Stada Arzneimittel Basic Information List
Table Stada Arzneimittel Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Stada Arzneimittel Parkinsons Disease Drug Sales Market Share (2011-2016)
Table Valeant Basic Information List
Table Valeant Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Valeant Parkinsons Disease Drug Sales Market Share (2011-2016)
Table Apokyn Basic Information List
Table Apokyn Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Apokyn Parkinsons Disease Drug Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Parkinsons Disease Drug
Figure Manufacturing Process Analysis of Parkinsons Disease Drug
Figure Parkinsons Disease Drug Industrial Chain Analysis
Table Raw Materials Sources of Parkinsons Disease Drug Major Manufacturers in 2015
Table Major Buyers of Parkinsons Disease Drug
Table Distributors/Traders List
Figure Germany Parkinsons Disease Drug Sales and Growth Rate Forecast (2016-2021)
Figure Germany Parkinsons Disease Drug Revenue and Growth Rate Forecast (2016-2021)
Figure France Parkinsons Disease Drug Sales and Growth Rate Forecast (2016-2021)
Figure France Parkinsons Disease Drug Revenue and Growth Rate Forecast (2016-2021)
Figure UK Parkinsons Disease Drug Sales and Growth Rate Forecast (2016-2021)
Figure UK Parkinsons Disease Drug Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Parkinsons Disease Drug Sales and Growth Rate Forecast (2016-2021)
Figure Russia Parkinsons Disease Drug Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Parkinsons Disease Drug Sales and Growth Rate Forecast (2016-2021)
Figure Italy Parkinsons Disease Drug Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Parkinsons Disease Drug Sales and Growth Rate Forecast (2016-2021)
Figure Spain Parkinsons Disease Drug Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Parkinsons Disease Drug Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Parkinsons Disease Drug Revenue and Growth Rate Forecast (2016-2021)
Table Europe Parkinsons Disease Drug Sales Forecast by Type (2016-2021)
Table Europe Parkinsons Disease Drug Sales Forecast by Application (2016-2021)